
Signos
Personalized nutrition timing
Our Verdict
The best CGM platform for weight-loss-focused users, with FDA-cleared weight management claims, AI-powered exercise timing, and GLP-1 medication support. Narrower in scope than Levels (general wellness) or Nutrisense (dietitian-guided), but more targeted and effective for users whose primary goal is body composition change.
Affiliate link - we may earn a commission
Last updated: October 2026
Pros
- RD access included in subscription
- Weight loss focused algorithms
Cons
- Less suited for performance athletes
Best For
- Users whose primary goal is weight loss and body composition improvement
- People on GLP-1 medications (Ozempic, Wegovy, Mounjaro) who want glucose monitoring support
- Goal-oriented individuals who respond well to AI-driven coaching and real-time exercise prompts
- Those who want an FDA-cleared weight management tool backed by glucose data
Not Ideal For
- Users seeking broad metabolic education beyond weight loss (Levels is more comprehensive)
- People who prefer human dietitian guidance over AI coaching (Nutrisense includes an RD)
- Budget-conscious users — 3-month commitment at $199–399/mo totals $600–1,200
- Those who have already identified their food triggers and no longer need continuous monitoring
In-Depth Review
What Is Signos?
Signos is a CGM-based weight management program that uses real-time glucose data and AI-powered coaching to help users lose weight by optimizing meal timing, food choices, and exercise windows. Unlike general metabolic awareness platforms like Levels or dietitian-guided services like Nutrisense, Signos is built explicitly around weight loss as its primary outcome, with an FDA-cleared claim for weight management support.
The platform combines continuous glucose monitoring with proprietary algorithms that identify each user's optimal eating and exercise windows based on their individual glucose patterns. Signos has also integrated GLP-1 medication support for users on semaglutide or tirzepatide, providing glucose monitoring and nutritional guidance tailored to the specific metabolic changes these medications produce. This focus on weight loss as the organizing principle — rather than general metabolic curiosity — sets Signos apart in a CGM market that often lacks a clear end goal.
How It Works
Signos subscriptions range from $199 to $399 per month depending on plan length, with CGM sensors included in the subscription. After completing a health assessment that captures your current weight, target weight, activity level, and medication status, Signos ships your CGM sensor and activates your AI coaching profile. The app monitors your glucose continuously and sends real-time notifications when it detects optimal windows for exercise (typically during or shortly after a glucose spike) to maximize calorie burn from glucose utilization.
The weight loss mechanism relies on two evidence-based principles: first, minimizing glucose spikes through food choices and meal composition, which reduces insulin-driven fat storage signals; and second, timing physical activity to coincide with elevated glucose, which channels the glucose into muscle energy rather than adipose tissue. The AI coach learns your patterns over time and refines its recommendations — by week three, it begins predicting which meals will spike your glucose and suggests preemptive modifications. For GLP-1 users, Signos adjusts its coaching to account for the appetite suppression and altered glucose dynamics these medications produce, helping users maintain adequate protein intake and micronutrient balance while losing weight.
Key Features
- AI-powered exercise timing: Real-time notifications recommending when to move based on current glucose levels, designed to maximize caloric efficiency of workouts
- Weight-loss-specific coaching: All recommendations are framed around body composition goals rather than general metabolic awareness, with weekly progress tracking tied to weight and glucose metrics
- GLP-1 integration: Tailored guidance for users on semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro/Zepbound), addressing the unique nutritional challenges of these medications including protein adequacy and micronutrient absorption
- FDA-cleared weight management claim: One of the few CGM platforms with regulatory clearance specifically for weight loss support, providing a level of validated credibility that general wellness CGMs lack
- Glucose spike prediction: The AI learns your food responses and predicts likely spikes before they happen, enabling preemptive food pairing adjustments like adding fat or protein to blunt an anticipated carbohydrate response
Interested in Signos?
Check the latest pricing and availability from the official store.
View Best PriceWhat Published Research and Owner Reviews Say
We haven't tested the Signos ourselves. This summary is based on Signos's published specifications, peer-reviewed studies where they exist, and owner reviews.
The Bottom Line
Signos is the strongest CGM platform for users whose primary goal is weight loss, offering FDA-cleared weight management support, AI-driven exercise timing, and emerging GLP-1 integration. Its narrow focus is both its strength and its limitation — it excels at body composition optimization but lacks the broader metabolic education of Levels or the human expertise of Nutrisense. Best suited for goal-oriented users who want their CGM data interpreted through a weight-loss lens and are motivated by real-time prompts to move and modify meals.
Frequently Asked Questions
Common questions about this topic
Ready to try Signos?
See the latest pricing and availability.
View Best PriceAffiliate link - we may earn a commission
Compare Signos
See how Signos stacks up against the competition
Related Products
Links may be affiliate links